Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin LAR for prevention of chemotherapy-induced diarrhea
2006-001150-27Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Aug 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of octreotide in diarrhea, sponsored by Ghent University Hospital. Primary endpoint: Effectiveness in secondary prevention. Started Aug 2006; status: completed.
02
Drugs
octreotide
03
Conditions
diarrhea
Beyond the preview
Go deeper on 2006-001150-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001150-27.